Global Point-Of-Care-Testing (POCT) Market
Medical Equipment

Point-Of-Care-Testing (POCT) Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Point-Of-Care-Testing (POCT) Market From 2025 To 2034?

The point-of-care-testing (POCT) market has experienced rapid expansion in recent years. Its valuation is set to climb from $45.45 billion in 2024 to $50.79 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. This historical growth can be ascribed to a heightened focus on personalized medicine, escalating investments within healthcare infrastructure, an increase in emergency care situations, the expanded utilization of point-of-care molecular testing, and the rising integration of AI in diagnostic processes.

The point-of-care-testing (POCT) market is anticipated to experience significant growth in the coming years. It is projected to expand to $78.19 billion by 2029, achieving a compound annual growth rate (CAGR) of 11.4%. The expansion during the forecast period can be attributed to factors such as increasing demand for personalized medicine, the rise of telehealth and remote monitoring trends, improved healthcare access in developing markets, the expanding application of POCT in non-traditional environments, and the rising adoption of wearable diagnostic devices. Key trends for the forecast period involve advancements in multiplex testing platforms, the creation of portable molecular diagnostic devices, innovations in smartphone-based diagnostic tools, progress in connectivity and data integration, and the development of AI-powered POCT solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

What Are The Key Drivers Of Growth In The Point-Of-Care-Testing (POCT) Market?

The expanding use of telemedicine is projected to fuel the growth of the point-of-care-testing (POCT) market moving forward. Telemedicine involves providing medical care remotely through digital communication platforms like video calls, phone conversations, or secure messaging. Its uptake stems from an increasing need for accessible, prompt, and contact-free healthcare, a demand significantly boosted by the COVID-19 pandemic. Point-of-care testing (POCT) complements telemedicine by delivering swift, accurate diagnostic outcomes that can be instantly shared with remote healthcare professionals. As an illustration, a survey conducted by Rock Health, a US-based health technology company, among 8,014 respondents from July 12 to August 22, 2022, revealed in February 2023 that 76% of individuals aged over 55 had utilized telemedicine. Furthermore, 80% of all respondents indicated having accessed care via telemedicine at some point, representing an 8% increase from 72% in 2021. Consequently, the growing integration of telemedicine is a key factor propelling the expansion of the point-of-care-testing (POCT) market.

What Are The Leading Segments Analyzed In The Point-Of-Care-Testing (POCT) Market?

The point-of-care-testing (POCT) market covered in this report is segmented

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Are The Major Trends Driving The Growth Of The Point-Of-Care-Testing (POCT) Market?

Leading companies in the point-of-care-testing (POCT) market are concentrating on creating innovative products, such as blood glucose management solutions, to enhance diagnostic speed, accuracy, and patient results in near-patient environments. Blood glucose management solutions denote the instruments, apparatuses, and systems utilized for monitoring, tracking, and regulating blood sugar levels to manage conditions like diabetes. For example, in January 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the Cobas pulse system. The Cobas pulse system presents a next-generation connected platform that merges advanced point-of-care blood glucose testing with smart device functionalities. It allows for effortless integration with hospital information technology (IT) systems for automatic result transmission and real-time clinical data availability. The device also supports healthcare applications to improve decision support and operational efficiency at the patient’s side.

Who Are The Key Multinational Companies Dominating The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

What Are The Regional Market Dynamics Impacting The Point-Of-Care-Testing (POCT) Industry?

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Point-Of-Care-Testing (POCT) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2025, By The Business Research Company

Precast Concrete Market 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Precast Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model